CD274 and adult T-cell leukemia/lymphoma: They also identified that PRKCB mutations and 9p24 (PD-L1) amplifications are poor independent prognostic factors in aggressive ATLL from known clinical prognostic factors: the Japan Clinical Oncology Group Prognostic Index (PI) [83] and age (<70 or ≥70 years) [84].